InChI
InChI=1S/C30H30F2N6O3/c1-6-23(40)36-12-13-37(18(5)15-36)28-19-14-21(32)26(24-20(31)8-7-9-22(24)39)34-29(19)38(30(41)35-28)27-17(4)10-11-33-25(27)16(2)3/h6-11,14,16,18,39H,1,12-13,15H2,2-5H3/t18-/m0/s1
InChI key
NXQKSXLFSAEQCZ-SFHVURJKSA-N
SMILES string
C[C@H]1CN(CCN1C2=NC(=O)N(C3=NC(=C(C=C32)F)C4=C(C=CC=C4F)O)C5=C(C=CN=C5C(C)C)C)C(=O)C=C
assay
≥98% (HPLC)
form
solid
color
off-white to yellow
mode of action
protein synthesis | inhibits
Quality Level
General description
Sotorasib (INN) is a small molecule which belongs to the class of compounds known as KRAS G12C inhibitors. Sotorasib is a chiral compound which is a KRAS G12C covalent inhibitor.
Biochem/physiol Actions
Sotorasib inhibits the KRAS G12C protein, which is involved in the regulation of cell growth and division. The KRAS G12C protein is a mutated form of the KRAS protein, which is found in certain types of cancer cells, particularly non-small cell lung cancer (NSCLC). The G12C mutation causes abnormal activation of the KRAS G12C protein, leading to the uncontrolled growth and spread of cancer cells.
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持